UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007022 |
|---|---|
| Receipt number | R000008284 |
| Scientific Title | Phase l and Phase ll Study of S-1+oxaliplatin (SOX)+cetuximab as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild type |
| Date of disclosure of the study information | 2012/01/06 |
| Last modified on | 2016/11/24 15:00:36 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/01/06 11:37:53 | ||
| 2 | Update | 2013/01/07 18:53:52 | Recruitment status |
|
| 3 | Update | 2013/07/10 05:14:37 | Recruitment status |
|
| 4 | Update | 2016/11/24 13:12:57 | Key inclusion criteria |
|
| 5 | Update | 2016/11/24 13:13:40 | Email Name of primary person or sponsor Organization |
|
| 6 | Update | 2016/11/24 13:14:07 | Recruitment status Publication of results |
|
| 7 | Update | 2016/11/24 15:00:36 | Recruitment status |
